PTSD • Transcend

Now Enrolling
Written By Kirsten Hirst

TSND201-PTSD-301

About the Study

For adults living with Post Traumatic Stress Disorder (PTSD)

The purpose of this study is to assess the efficacy, safety, and tolerability of TSND-201 for the treatment of PTSD symptoms compared to placebo

This study is sponsored by Transcend Therapeutics, Inc.

Eligibility

You may be eligible to participate in this study if you:

  • are at least 18 years of age

  • meet DSM-5 criteria for severe PTSD with symptom duration of at least 6 months

  • tried at least one pharmacological treatment for PTSD or trauma-focused psychotherapy

  • are free from any other clinically significant illnesses and diseases that may adversely affect participant safety or study integrity determined by the medical monitor or principal investigator.

  • are able to swallow and retain oral medications

Apply Today

If you are interested in participating in this clinical trial, please call our friendly staff at 801-871-5516 today. You can also fill out the contact form below.

 
Kirsten Hirst
Previous

Depression • Cybin
Next

Anxiety • MindMed